Immune Therapeutics, Inc. Stock Price - IMUN

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
SMALL CAP BASIC
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Immune Therapeutics, Inc. IMUN Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.00% 0.006 0.0065 0.0051 0.0063 0.006 15:58:13
Bid Price Ask Price Spread Spread % News
0.0052 0.006 0.0008 13.33% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
15 791,385 $ 0.005895 $ 4,665 566,600 0.0027 - 0.03
Last Trade Time Type Quantity Stock Price Currency
15:58:13 10,000 $ 0.006 USD

Immune Therapeutics, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.73M 455.58M $ -8.18M - -0.33 7.99M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Immune Therapeutics, Inc. News

Latest IMUN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IMUN Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.00560.00660.00510.0062101k791k218k0.00047.14%
1 Month0.00580.0070.00450.00655003M486k0.00023.45%
3 Months0.0070.01240.00450.00785003M600k-0.001-14.29%
6 Months0.005830.01660.00270.00745006M712k0.000172.92%
1 Year0.02650.030.00270.01035006M755k-0.0205-77.36%
3 Years0.1660.1860.00270.032150013M746k-0.16-96.39%
5 Years0.3450.420.00270.05536213M541k-0.339-98.26%

Immune Therapeutics, Inc. Description

Immune Therapeutics, Inc. is a biotechnology company developing and seeking to commercialize patented therapies in emerging nations that combat chronic, life-threatening diseases by stimulating or rebalancing the immune system. Our technology platform is based on two interrelated cytokine drug therapies-Low-Dose Naltrexone (LDN) and Methionine Enkephalin (MENK)-which work by triggering opioid receptors on immune cells to activate various cells of the immune system.


Your Recent History
USOTC
IMUN
Immune The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.